51³ΙΘΛΆ―Βώ

Meeting Coverage

FSR

Florida Society of Rheumatology

CV Risk in RA: Questions Remain

TARGET study should fill in the clinical gaps

image

Latest FSR Meeting Coverage

Rheumatic Adverse Events on the Rise with Cancer Therapies

With immune checkpoint inhibition, rheumatic adverse events may become more common than RA

July 15, 2018